Physician profile
Cory A Gaiser
NPI 1306279088
$2,113.28
in general payments reported to CMS, 2019-2025
18 companies · $71.58 in 2025
The $71.58 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,110 · 2020: $106 · 2021: $499 · 2024: $327 · 2025: $71.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $236 · Travel and Lodging: $162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $236.05 |
| Travel and Lodging | $162.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $427.51 | 2021 | |
| Allergan, INC. | $304.68 | 2019-2020 | |
| Merz North America, INC. | $275.33 | 2019-2024 | |
| Lilly USA, LLC | $267.58 | 2019-2025 | Zepbound |
| Stryker Corporation | $258.33 | 2024 | Everest Spinal System |
| Teva Pharmaceuticals USA, INC. | $132.36 | 2019 | |
| Galderma Laboratories, L.P. | $107.64 | 2019 | |
| Radius Health, INC. | $94.21 | 2019 | |
| Janssen Pharmaceuticals, INC | $53.32 | 2019-2020 | |
| Novo Nordisk INC | $44.64 | 2019-2025 | Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.08 | 2019 | |
| Amgen INC. | $28.16 | 2019 | |
| Hologic Sales and Service, LLC | $18.31 | 2021 | |
| Mentor Worldwide LLC | $17.58 | 2025 | Artoura Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer |
| Grifols USA, LLC | $16.14 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $14.04 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $12.79 | 2019 | |
| Pfizer INC. | $11.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cory Gaiser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.